PE20121029A1 - Marcadores de riesgo para enfermedad cardiovascular - Google Patents
Marcadores de riesgo para enfermedad cardiovascularInfo
- Publication number
- PE20121029A1 PE20121029A1 PE2011002069A PE2011002069A PE20121029A1 PE 20121029 A1 PE20121029 A1 PE 20121029A1 PE 2011002069 A PE2011002069 A PE 2011002069A PE 2011002069 A PE2011002069 A PE 2011002069A PE 20121029 A1 PE20121029 A1 PE 20121029A1
- Authority
- PE
- Peru
- Prior art keywords
- seq
- subject
- cardiovascular disease
- sample
- destined
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
REFERIDA A UN PROCEDIMIENTO PARA DETERMINAR SI UN SUJETO PRESENTA UN RIESGO AUMENTADO DE PADECER UNA ENFERMEDAD O TRASTORNO CARDIOVASCULAR ADVERSO O PARA DETERMINAR LA RESPUESTA FRENTE A UNA TERAPIA CARDIOVASCULAR EN UN SUJETO QUE COMPRENDE LAS ETAPAS DE DTERMINAR, EN UNA MUESTRA AISLADA DE DICHO SUJETO, LA PRESENCIA DE POLIMORFISMOS EN LAS POSICIONES 27 DENTREO DE LAS SECUENCIAS ACIDOS NUCLEICOS DE LA SEC ID NO:1 A 11, EN EL QUE LA PRESENCIA DE UNA C EN LA POSICION 27 EN LA SEC ID NO: 1, DE A EN LA SEC ID NO:2, DE C EN LA SEC ID NO:3, DE T EN LA SEC ID NO:4, DE C EN LA SEC ID NO:5, DE A EN LA SEC ID NO:6, DE T EN LA SEC ID NO:7, DE C EN LA SEC ID NO:8, DE C EN LA SEC ID NO:9, DE T EN LA SEC ID NO:9, DE T EN LA SEC ID NO:10 Y DE T EN LA SEC ID NO:11 ES INDICATIVA DE UN RIESGO AUMENTADO DE PADECER UNA ENFERMEDAD CARDIOVASCULAR SELECCIONADA DE INFARTO DE MIOCARDIO, ANGINA DE PECHO, ATAQUES ISQUEMICOS, INSUFICIENCIA CARDIACA CONGESTIVA, ANEURISMA AORTICO, ENTRE OTROS O UNA COMBINACION DE LOS MISMOS. DICHA MUESTRA ES UN TEJIDO O MUESTRA DE TEJIDO ORAL, RASPADO O LAVADO O UNA MUESTRA BIOLOGICA, DE PREFERENCIA SALIVA, ORINA O SANGRE
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09162329.8A EP2264183B1 (en) | 2009-06-09 | 2009-06-09 | Risk markers for cardiovascular disease |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20121029A1 true PE20121029A1 (es) | 2012-08-09 |
Family
ID=41061079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2011002069A PE20121029A1 (es) | 2009-06-09 | 2010-06-09 | Marcadores de riesgo para enfermedad cardiovascular |
Country Status (14)
Country | Link |
---|---|
US (1) | US9957565B2 (es) |
EP (2) | EP2264183B1 (es) |
AR (1) | AR077026A1 (es) |
AU (1) | AU2010257482B2 (es) |
BR (1) | BRPI1013082A2 (es) |
CA (1) | CA2764693C (es) |
CL (1) | CL2011003129A1 (es) |
ES (2) | ES2623633T3 (es) |
MX (1) | MX2011013243A (es) |
PE (1) | PE20121029A1 (es) |
PT (2) | PT2264183T (es) |
RU (1) | RU2524659C2 (es) |
UY (1) | UY32698A (es) |
WO (1) | WO2010142713A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
SG186953A1 (en) | 2010-07-09 | 2013-02-28 | Somalogic Inc | Lung cancer biomarkers and uses thereof |
MX341517B (es) | 2010-08-13 | 2016-08-24 | Somalogic Inc | Biomarcadores de cancer pancreatico y usos de los mismos. |
DK2554679T3 (en) * | 2011-08-05 | 2016-04-04 | Gendiag Exe Sl | Genetic markers for risk assessment for cardiovascular disease |
MX2014003153A (es) * | 2011-09-30 | 2014-04-30 | Somalogic Inc | Prediccion de riesgo de evento cardiovascular y usos del mismo. |
EP2843056B8 (en) * | 2013-08-30 | 2019-06-26 | GENINCODE UK, Ltd. | Risk markers for cardiovascular disease in patients with chronic kidney disease |
RU2547575C1 (ru) * | 2014-02-06 | 2015-04-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Способ прогнозирования течения хронической сердечной недостаточности |
RU2602451C1 (ru) * | 2015-08-28 | 2016-11-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого" Министерства здравоохранения Российской Федерации | Способ диагностики генетической предрасположенности к развитию ишемического инсульта у больных с фибрилляцией предсердий |
WO2017062599A1 (en) * | 2015-10-07 | 2017-04-13 | The Board Of Trustees Of The Leland Stanford Junior University | Techniques for determining whether an individual is included in ensemble genomic data |
RU2624859C1 (ru) * | 2016-06-15 | 2017-07-07 | Общество с ограниченной ответственностью "Меднорд-Техника" (ООО "Меднорд-Техника") | Способ оценки повышенного риска возникновения флеботромбозов у пациентов с ишемической болезнью сердца |
CN106250524A (zh) * | 2016-08-04 | 2016-12-21 | 浪潮软件集团有限公司 | 一种基于语义信息的机构名抽取方法和装置 |
US10451544B2 (en) | 2016-10-11 | 2019-10-22 | Genotox Laboratories | Methods of characterizing a urine sample |
WO2019191010A1 (en) * | 2018-03-27 | 2019-10-03 | Aardvark Therapeutics Inc. | Personalized treatment method for congestive heart failure |
US11308325B2 (en) * | 2018-10-16 | 2022-04-19 | Duke University | Systems and methods for predicting real-time behavioral risks using everyday images |
CN110229881A (zh) * | 2019-07-03 | 2019-09-13 | 贵州省临床检验中心 | 一种与成人心血管疾病相关的snp分子标记及其应用 |
CN110229882A (zh) * | 2019-07-03 | 2019-09-13 | 贵州省临床检验中心 | 一种与心血管疾病相关的mthfr基因分子标记及其应用 |
CN112210598A (zh) * | 2019-07-11 | 2021-01-12 | 合肥中科普瑞昇生物医药科技有限公司 | 检测高血糖药物代谢相关基因多态性的引物组和试剂盒及它们的应用 |
CN110607360A (zh) * | 2019-09-19 | 2019-12-24 | 华中科技大学同济医学院附属同济医院 | 一种评估慢性心力衰竭预后的引物组、试剂盒及评估慢性心力衰竭预后的方法 |
US20240002935A1 (en) * | 2020-04-11 | 2024-01-04 | Geneticure Inc. | Genetic method for diagnosis and treatment of pre and post coronavirus infections |
US11610645B2 (en) * | 2020-04-30 | 2023-03-21 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
US11967430B2 (en) | 2020-04-30 | 2024-04-23 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
US11574738B2 (en) | 2020-04-30 | 2023-02-07 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
US11978532B2 (en) | 2020-04-30 | 2024-05-07 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
US11482302B2 (en) | 2020-04-30 | 2022-10-25 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US723961A (en) | 1902-10-01 | 1903-03-31 | Nelson W Clark | Lady's belt, collar, or the like. |
US4883750A (en) | 1984-12-13 | 1989-11-28 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
US5004565A (en) | 1986-07-17 | 1991-04-02 | The Board Of Governors Of Wayne State University | Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes |
US5856522A (en) | 1995-05-04 | 1999-01-05 | Tropix, Inc. | Method of using synthesis of 1,2-dioxetanes and kits therefore |
US5994073A (en) | 1990-08-30 | 1999-11-30 | Tropix, Inc. | Enhancement of chemiluminescent assays |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
WO1995011995A1 (en) | 1993-10-26 | 1995-05-04 | Affymax Technologies N.V. | Arrays of nucleic acid probes on biological chips |
US6015880A (en) | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US5773628A (en) | 1994-11-14 | 1998-06-30 | Tropix, Inc. | 1,2-dioxetane compounds with haloalkoxy groups, methods preparation and use |
US5591591A (en) | 1995-02-09 | 1997-01-07 | Tropix, Inc. | Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore |
US5589136A (en) | 1995-06-20 | 1996-12-31 | Regents Of The University Of California | Silicon-based sleeve devices for chemical reactions |
US5679803A (en) | 1995-10-25 | 1997-10-21 | Tropix, Inc. | 1,2 chemiluminescent dioxetanes of improved performance |
US5885470A (en) | 1997-04-14 | 1999-03-23 | Caliper Technologies Corporation | Controlled fluid transport in microfabricated polymeric substrates |
US5800999A (en) | 1996-12-16 | 1998-09-01 | Tropix, Inc. | Dioxetane-precursor-labeled probes and detection assays employing the same |
KR100351531B1 (ko) | 1997-04-25 | 2002-09-11 | 캘리퍼 테크놀로지스 코포레이션 | 기하형상이 개선된 채널을 채용하는 미소 유체 장치 |
US6159693A (en) | 1998-03-13 | 2000-12-12 | Promega Corporation | Nucleic acid detection |
WO2002072889A2 (en) | 2001-01-12 | 2002-09-19 | Applera Corporation | Methods and compositions for microarray control |
US20070015170A1 (en) * | 2005-07-12 | 2007-01-18 | Oy Jurilab Ltd | Method and kit for detecting a risk of coronary heart disease |
RU2322193C1 (ru) | 2006-12-04 | 2008-04-20 | Федеральное государственное учреждение "Учебно-научный медицинский центр" Управления делами Президента Российской Федерации | Способ оценки генетического риска сердечно-сосудистых заболеваний у спортсменов |
SG178811A1 (en) * | 2007-02-21 | 2012-03-29 | Decode Genetics Ehf | Genetic susceptibility variants associated with cardiovascular disease |
US7883851B2 (en) | 2007-05-02 | 2011-02-08 | Board Of Regents, The University Of Texas System | Common allele on chromosome 9 associated with coronary heart disease |
-
2009
- 2009-06-09 PT PT91623298T patent/PT2264183T/pt unknown
- 2009-06-09 EP EP09162329.8A patent/EP2264183B1/en not_active Not-in-force
- 2009-06-09 ES ES09162329.8T patent/ES2623633T3/es active Active
-
2010
- 2010-06-09 PE PE2011002069A patent/PE20121029A1/es not_active Application Discontinuation
- 2010-06-09 CA CA2764693A patent/CA2764693C/en active Active
- 2010-06-09 WO PCT/EP2010/058064 patent/WO2010142713A1/en active Application Filing
- 2010-06-09 ES ES10725412.0T patent/ES2627446T3/es active Active
- 2010-06-09 PT PT107254120T patent/PT2440674T/pt unknown
- 2010-06-09 AU AU2010257482A patent/AU2010257482B2/en not_active Ceased
- 2010-06-09 RU RU2011154171/15A patent/RU2524659C2/ru not_active IP Right Cessation
- 2010-06-09 EP EP10725412.0A patent/EP2440674B1/en not_active Not-in-force
- 2010-06-09 MX MX2011013243A patent/MX2011013243A/es active IP Right Grant
- 2010-06-09 US US13/377,216 patent/US9957565B2/en active Active
- 2010-06-09 UY UY0001032698A patent/UY32698A/es unknown
- 2010-06-09 AR ARP100102016A patent/AR077026A1/es unknown
- 2010-06-09 BR BRPI1013082A patent/BRPI1013082A2/pt not_active IP Right Cessation
-
2011
- 2011-12-09 CL CL2011003129A patent/CL2011003129A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2264183B1 (en) | 2016-12-07 |
EP2440674A1 (en) | 2012-04-18 |
CA2764693C (en) | 2017-07-11 |
CL2011003129A1 (es) | 2012-04-27 |
US9957565B2 (en) | 2018-05-01 |
CA2764693A1 (en) | 2010-12-16 |
US20120141450A1 (en) | 2012-06-07 |
AU2010257482A1 (en) | 2012-02-02 |
AU2010257482B2 (en) | 2014-01-23 |
EP2264183A1 (en) | 2010-12-22 |
AR077026A1 (es) | 2011-07-27 |
UY32698A (es) | 2010-11-30 |
RU2524659C2 (ru) | 2014-07-27 |
ES2623633T3 (es) | 2017-07-11 |
PT2440674T (pt) | 2017-05-23 |
EP2440674B1 (en) | 2017-04-05 |
WO2010142713A1 (en) | 2010-12-16 |
PT2264183T (pt) | 2017-03-14 |
BRPI1013082A2 (pt) | 2016-07-26 |
ES2627446T3 (es) | 2017-07-28 |
MX2011013243A (es) | 2012-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20121029A1 (es) | Marcadores de riesgo para enfermedad cardiovascular | |
Tyser et al. | Calcium handling precedes cardiac differentiation to initiate the first heartbeat | |
CN104379740B (zh) | 新型fgfr3融合体 | |
Medioni et al. | Expression of Slit and Robo genes in the developing mouse heart | |
Driscoll et al. | Inflammatory and biomechanical drivers of endothelial-interstitial interactions in calcific aortic valve disease | |
Jakob et al. | Piezo1 and BKCa channels in human atrial fibroblasts: Interplay and remodelling in atrial fibrillation | |
EA200970781A1 (ru) | Варианты генетической предрасположенности, связанные с сердечно-сосудистыми заболеваниями | |
NO20092530L (no) | Genetiske markorer for risikohandtering av hjertearrytmi | |
JP7079937B2 (ja) | 肺血管疾患を治療するための組成物および方法 | |
CY1116178T1 (el) | Αναστολεις των lox και loxl2 και χρησεις εξ' αυτων | |
ATE437965T1 (de) | Doppelsträngige sonden zur fluoreszenzdetektion von nukleinsäuren | |
RU2021134325A (ru) | Производные хинолина для лечения воспалительных заболеваний | |
WO2010007031A3 (en) | Methods for improving cardiac differentiation of human embryonic stem cells | |
DE602006012995D1 (de) | Brustkrebsdiagnoseverfahren | |
WO2008132763A3 (en) | Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction | |
AR088294A1 (es) | Determinacion de polimorfismos de un nucleotido simple utiles para predecir la respuesta clinica al acetato de glatiramero | |
FR2924118B1 (fr) | Fragments d'anticorps inhibiteurs de la proteine nef du vih. | |
JP2015521475A5 (es) | ||
JP2018500884A5 (es) | ||
JP2007536913A5 (es) | ||
BRPI0809143B8 (pt) | método in vitro para identificar um indivíduo que apresente um risco alterado para desenvolver doença cardíaca coronária (chd) ou aneurisma/dissecção | |
ITNA20080006A1 (it) | Proteine chimeriche capaci di formare particelle virus-like, che contengono sequenze peptidiche del beta-amiloide e la componente e2 della alfachetoacido deidrogenasi di "geobacillus stearothermophilus", utili per l'induzione di una risposta anticorp | |
NO20070780L (no) | Celloverflateprotein. | |
CO6430477A2 (es) | Sondas y cebadores para la deteccion de malaria | |
FR2930036B1 (fr) | Procede de diagnostic d'une hypertension arterielle pulmonaire. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |